A phase 1b, open-label study of trebananib plus bevacizumab or motesanib in patients with solid tumours

por Hong, David S., Kurzrock, Razelle, Mulay, Marilyn, Rasmussen, Erik, Wu, Benjamin M., Bass, Michael B., Zhong, Zhandong D., Friberg, Greg, Rosen, Lee S.
Publicado 2014

Challenges in Developing a Validated Biomarker for Angiogenesis Inhibitors: The Motesanib Experience

por Bass, Michael B., Yao, Bin, Hei, Yong-Jiang, Ye, Yining, Davis, Gerard J., Davis, Michael T., Kaesdorf, Barbara A., Chan, Sabrina S., Patterson, Scott D.
Publicado 2014

Development of an eHealth System to Capture and Analyze Patient Sensor and Self-Report Data: Mixed-Methods Assessment of Potential Applications to Improve Cancer Care Delivery

por Lucas, Alexander R, Bass, Michael B, Rothrock, Nan E, O'Connor, Mary L, Sorkin, Mia R, Nawyn, Jason, Albinali, Fahd, Wagner, Lynne I
Publicado 2018

Sources of variation in baseline gene expression levels from toxicogenomics study control animals across multiple laboratories

por Boedigheimer, Michael J, Wolfinger, Russell D, Bass, Michael B, Bushel, Pierre R, Chou, Jeff W, Cooper, Matthew, Corton, J Christopher, Fostel, Jennifer, Hester, Susan, Lee, Janice S, Liu, Fenglong, Liu, Jie, Qian, Hui-Rong, Quackenbush, John, Pettit, Syril, Thompson, Karol L
Publicado 2008